Gordon J.S. Rustin
Impact in
- Reproductive Medicine top 0.05%
- Ovarian cancer diagnosis and treatment
- Oncology top 0.5%
- PARP inhibition in cancer therapy
Papers in
-
- Ovarian cancer diagnosis and treatment 92
- Surgery 74
- Testicular diseases and treatments 52
- Intraperitoneal and Appendiceal Malignancies 17
- Co-authors
- Edward S. Newlands (52 shared papers)Richard H. J. Beǵent (37 shared papers)Lydia Holden (26 shared papers)Jonathan A. Ledermann (21 shared papers)Anwar R. Padhani (12 shared papers)K. D. Bagshawe (28 shared papers)Michael Leonard Friedlander (14 shared papers)Charlie Gourley (14 shared papers)
- Journals
- British Journal of Cancer (30 papers)Journal of Clinical Oncology (26 papers)Annals of Oncology (18 papers)European Journal of Cancer (16 papers)Gynecologic Oncology (14 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Gordon J.S. Rustin
240 papers receiving 19.6k citations
Gordon J.S. Rustin's Hit Papers
Peers
Comparison fields: 5 of 151
- Reproductive Medicine 5.2k
- Oncology 5.3k
- Obstetrics and Gynecology 1.4k
- Internal Medicine 404
- Radiology, Nuclear Medicine and Imaging 2.5k
Countries citing papers authored by Gordon J.S. Rustin
This map shows the geographic impact of Gordon J.S. Rustin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon J.S. Rustin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon J.S. Rustin more than expected).
Fields of papers citing papers by Gordon J.S. Rustin
This network shows the impact of papers produced by Gordon J.S. Rustin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon J.S. Rustin. The network helps show where Gordon J.S. Rustin may publish in the future.
Co-authors
The 25 scholars most cited alongside Gordon J.S. Rustin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 241 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations Hit paper breakdown → | 2009 | 1686 |
| 2 | Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer Hit paper breakdown → | 2012 | 1543 |
| 3 | Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial Hit paper breakdown → | 2014 | 1213 |
| 4 | CARBOPLATIN OR CISPLATIN? Hit paper breakdown → | 1988 | 1089 |
| 5 | Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial Hit paper breakdown → | 2015 | 700 |
| 6 | Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS) Hit paper breakdown → | 2004 | 552 |
| 7 | Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial Hit paper breakdown → | 2010 | 436 |
| 8 | 2005 | 435 | |
| 9 | 2016 | 367 | |
| 10 | 2002 | 301 | |
| 11 | 2003 | 295 | |
| 12 | 2003 | 285 | |
| 13 | 1997 | 250 | |
| 14 | Phase I trial of temozolomide using an extended continuous oral schedule. | 1998 | 249 |
| 15 | 1995 | 244 | |
| 16 | 2005 | 241 | |
| 17 | 2000 | 222 | |
| 18 | 2018 | 217 | |
| 19 | 2011 | 213 | |
| 20 | 2003 | 200 |
About Gordon J.S. Rustin
Gordon J.S. Rustin is a scholar working on Reproductive Medicine, Surgery, Oncology, Obstetrics and Gynecology and Public Health, Environmental and Occupational Health, having authored 241 papers that have together received 20.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (92 papers), Testicular diseases and treatments (52 papers), Gestational Trophoblastic Disease Studies (32 papers), PARP inhibition in cancer therapy (23 papers), Endometrial and Cervical Cancer Treatments (19 papers), Intraperitoneal and Appendiceal Malignancies (17 papers), Neuroblastoma Research and Treatments (14 papers) and MRI in cancer diagnosis (10 papers). The work is most often cited by research in Reproductive Medicine (5.2k citations), Oncology (5.3k citations), Obstetrics and Gynecology (1.4k citations), Internal Medicine (404 citations) and Radiology, Nuclear Medicine and Imaging (2.5k citations). Gordon J.S. Rustin has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Edward S. Newlands, Richard H. J. Beǵent, Lydia Holden, Jonathan A. Ledermann, Anwar R. Padhani, K. D. Bagshawe, Michael Leonard Friedlander, Charlie Gourley, Ignace B. Vergote and Philipp Harter. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.